{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:25:33Z","timestamp":1740126333374,"version":"3.37.3"},"reference-count":55,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast J"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/tbj.13116","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T03:34:03Z","timestamp":1537932843000},"page":"902-910","source":"Crossref","is-referenced-by-count":7,"title":["Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations"],"prefix":"10.1155","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4099-712X","authenticated-orcid":false,"given":"Adam","family":"Currey","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin R.","family":"Patten","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Bergom","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Frank","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Surgery; Medical College of Wisconsin; Milwaukee Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"issue":"5","key":"10.1111\/tbj.13116-BIB0001|tbj13116-cit-0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1111\/tbj.13116-BIB0002|tbj13116-cit-0002","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1111\/tbj.13116-BIB0003|tbj13116-cit-0003","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"issue":"5","key":"10.1111\/tbj.13116-BIB0004|tbj13116-cit-0004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0005|tbj13116-cit-0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Annals of surgery"},{"issue":"12","key":"10.1111\/tbj.13116-BIB0006|tbj13116-cit-0006","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejso.2008.01.034","article-title":"Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature","volume":"34","author":"Ploeg","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"18","key":"10.1111\/tbj.13116-BIB0007|tbj13116-cit-0007","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","article-title":"Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review","volume":"45","author":"Deurzen","year":"2009","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0008|tbj13116-cit-0008","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","article-title":"Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation","volume":"14","author":"Newman","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0009|tbj13116-cit-0009","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1111\/tbj.13116-BIB0010|tbj13116-cit-0010","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"issue":"36","key":"10.1111\/tbj.13116-BIB0011|tbj13116-cit-0011","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1111\/tbj.13116-BIB0012|tbj13116-cit-0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","article-title":"Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy","volume":"230","author":"Kuerer","year":"1999","journal-title":"Ann Surg"},{"issue":"1","key":"10.1111\/tbj.13116-BIB0013|tbj13116-cit-0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/caac.20001","article-title":"Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment","volume":"59","author":"Lawenda","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"8442","key":"10.1111\/tbj.13116-BIB0014|tbj13116-cit-0014","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(85)91807-0","article-title":"Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients","volume":"1","author":"Mazeron","year":"1985","journal-title":"Lancet"},{"issue":"5","key":"10.1111\/tbj.13116-BIB0015|tbj13116-cit-0015","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0360-3016(02)04273-6","article-title":"Risk of lymphedema after regional nodal irradiation with breast conservation therapy","volume":"55","author":"Coen","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0016|tbj13116-cit-0016","first-page":"515","article-title":"Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial","volume":"155","author":"Borup Christensen","year":"1989","journal-title":"Acta Chir Scand"},{"issue":"3","key":"10.1111\/tbj.13116-BIB0017|tbj13116-cit-0017","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","article-title":"Improved axillary staging of breast cancer with sentinel lymphadenectomy","volume":"222","author":"Giuliano","year":"1995","journal-title":"Ann Surg"},{"issue":"3","key":"10.1111\/tbj.13116-BIB0018|tbj13116-cit-0018","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0019|tbj13116-cit-0019","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0020|tbj13116-cit-0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1111\/tbj.13116-BIB0021|tbj13116-cit-0021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9610(03)00168-5","article-title":"Sentinel node biopsy prior to neoadjuvant chemotherapy","volume":"186","author":"Sabel","year":"2003","journal-title":"Am J Surg"},{"issue":"2","key":"10.1111\/tbj.13116-BIB0022|tbj13116-cit-0022","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"issue":"25","key":"10.1111\/tbj.13116-BIB0023|tbj13116-cit-0023","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","article-title":"Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32","volume":"28","author":"Land","year":"2010","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1111\/tbj.13116-BIB0024|tbj13116-cit-0024","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1111\/tbj.13116-BIB0025|tbj13116-cit-0025","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/annonc\/mdt182","article-title":"Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)","volume":"24","author":"Schneeweiss","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1111\/tbj.13116-BIB0026|tbj13116-cit-0026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1111\/tbj.13116-BIB0027|tbj13116-cit-0027","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.22540","article-title":"Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases","volume":"109","author":"Shen","year":"2007","journal-title":"Cancer"},{"issue":"5","key":"10.1111\/tbj.13116-BIB0028|tbj13116-cit-0028","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1111\/tbj.13116-BIB0029|tbj13116-cit-0029","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1111\/tbj.13116-BIB0030|tbj13116-cit-0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1111\/tbj.13116-BIB0031|tbj13116-cit-0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1111\/tbj.13116-BIB0032|tbj13116-cit-0032","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1200\/JOP.2016.019992","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: 2016 American Society of Clinical Oncology Clinical practice guideline update summary","volume":"13","author":"Lyman","year":"2017","journal-title":"J Oncol Pract"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0033|tbj13116-cit-0033","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0034|tbj13116-cit-0034","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1111\/tbj.13116-BIB0035|tbj13116-cit-0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1111\/tbj.13116-BIB0036|tbj13116-cit-0036","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"10.1111\/tbj.13116-BIB0037|tbj13116-cit-0037","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2001.19.5.1539","article-title":"Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Recht","year":"2001","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0038|tbj13116-cit-0038","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijrobp.2008.10.080","article-title":"ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast","volume":"73","author":"Taylor","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/tbj.13116-BIB0039|tbj13116-cit-0039","unstructured":"Network NCC. Breast Cancer (Version 2.2017) 2017"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0040|tbj13116-cit-0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0041|tbj13116-cit-0041","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/tbj.13116-BIB0042|tbj13116-cit-0042","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.prro.2016.08.009","article-title":"Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update","volume":"6","author":"Recht","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"12","key":"10.1111\/tbj.13116-BIB0043|tbj13116-cit-0043","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1111\/tbj.13116-BIB0044|tbj13116-cit-0044","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1111\/tbj.13116-BIB0045|tbj13116-cit-0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2009.08.053","article-title":"Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?","volume":"78","author":"Daveau","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15_suppl","key":"10.1111\/tbj.13116-BIB0046|tbj13116-cit-0046","doi-asserted-by":"crossref","first-page":"TPS1141","DOI":"10.1200\/jco.2014.32.15_suppl.tps1141","article-title":"NSABP B-51\/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC","volume":"32","author":"Mamounas","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0047|tbj13116-cit-0047","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0360-3016(02)02850-X","article-title":"Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy","volume":"53","author":"Buchholz","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1111\/tbj.13116-BIB0048|tbj13116-cit-0048","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cncr.27717","article-title":"Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1111\/tbj.13116-BIB0049|tbj13116-cit-0049","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","article-title":"Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"12","author":"King","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0050|tbj13116-cit-0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1111\/tbj.13116-BIB0051|tbj13116-cit-0051","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1245\/ASO.2006.03.010","article-title":"Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic","volume":"13","author":"Klauber-DeMore","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1111\/tbj.13116-BIB0052|tbj13116-cit-0052","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2009.04.059","article-title":"The association between biological subtype and isolated regional nodal failure after breast-conserving therapy","volume":"77","author":"Wo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1111\/tbj.13116-BIB0053|tbj13116-cit-0053","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2009.23.7610","article-title":"Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"28","author":"Mamounas","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1111\/tbj.13116-BIB0054|tbj13116-cit-0054","doi-asserted-by":"crossref","first-page":"djw259","DOI":"10.1093\/jnci\/djw259","article-title":"21-gene recurrence score and locoregional recurrence in node-positive\/ER-positive breast cancer treated with chemo-endocrine therapy","volume":"109","author":"Mamounas","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1111\/tbj.13116-BIB0055|tbj13116-cit-0055","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10549-011-1891-6","article-title":"Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype","volume":"133","author":"Lowery","year":"2012","journal-title":"Breast Cancer Res Treat"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftbj.13116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tbj.13116\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T19:00:35Z","timestamp":1662145235000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tbj.13116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1111\/tbj.13116","archive":["Portico"],"relation":{},"ISSN":["1075-122X"],"issn-type":[{"type":"print","value":"1075-122X"}],"subject":[],"published":{"date-parts":[[2018,9,25]]}}}